NCT06342167 2024-06-11
Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Active not recruiting
Clinical Trials
1 trialsPhase 2 × Locally Advanced Esophageal Squamous Cell Carcinoma × Immune Checkpoint Inhibitors × Clear all